MWE Correspondent
In a groundbreaking medical breakthrough, scientists in China have successfully reversed type 1 diabetes in a 25-year-old woman using stem cell therapy—marking the first time this has ever been achieved.
The team reprogrammed the patient’s own fat cells into insulin–producing cells, which were then transplanted into her abdomen. By day 75 following the procedure, she began producing insulin naturally. Remarkably, she has remained insulin-free for over a year without the need for external insulin or immune-suppressing drugs.
Also Read:Karim Khan To Step Aside Until Probe Into Alleged Misconduct Ends
This revolutionary method eliminates the risk of immune rejection by using the patient’s own cells, making it a promising solution for long-term diabetes management. Type 1 diabetes, an autoimmune condition where the body attacks insulin-producing cells in the pancreas, has traditionally required lifelong insulin therapy.
The success of this ongoing clinical trial offers renewed hope to millions of people around the world living with type 1 diabetes. If further trials confirm its safety and effectiveness, the therapy could represent a transformative step toward a permanent cure.
Medical experts say this breakthrough may also open doors to similar cell-based therapies for other autoimmune and chronic conditions.
